Applications of commercial biosensors in clinical, food, environmental, and biothreat/biowarfare analyses
Özet
The lack of specific, low-cost, rapid, sensitive, and easy detection of biomolecules has resulted in the development of biosensor technology. Innovations in biosensor technology have enabled many biosensors to be commercialized and have enabled biomolecules to be detected onsite. Moreover, the emerging technologies of lab-on-a-chip microdevices and nanosensors offer opportunities for the development of new biosensors with much better performance. Biosensors were first introduced into the laboratory by Clark and Lyons. They developed the first glucose biosensor for laboratory conditions. Then in 1973, a glucose biosensor was commercialized by Yellow Springs Instruments. The commercial biosensors have small size and simple construction and they are ideal for point-of-care biosensing. In addition to glucose, a wide variety of metabolites such as lactate, cholesterol, and creatinine can be detected by using commercial biosensors. Like the glucose biosensors (tests) other commercial tests such as for pregnancy (hCG), Escherichia coli 0157, influenza A and B viruses, Helicobacter pylori, human immunodeficiency virus, tuberculosis, and malaria have achieved success. Apart from their use in clinical analysis, commercial tests are also used in environmental (such as biochemical oxygen demand, nitrate, pesticide), food (such as glutamate, glutamine, sucrose, lactose, alcohol, ascorbic acid), and biothreat/biowarfare (Bacillus anthracis, Salmonella, Botulinum toxin) analysis. In this review, commercial biosensors in clinical, environmental, food, and biowarfare analysis are summarized and the commercial biosensors are compared in terms of their important characteristics. This is the first review in which all the commercially available tests are compiled together. (C) 2015 Elsevier Inc. All rights reserved.
Cilt
478İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Ultrasensitive and Selective Impedimetric Determination of Prostate Specific Membrane Antigen Based on Di-Succinimide Functionalized Polythiophene Covered Cost-Effective Indium Tin Oxide
Aydın, Elif Burcu; Aydın, Muhammet; Sezgintürk, Mustafa Kemal (John Wiley and Sons Inc, 2021)A new and ultrasensitive impedimetric biosensor fabricated by using conjugated di-succinimide substituted polythiophene (P(ThidiSuc)) polymer modified indium tin oxide electrode is developed for the first time to detect ... -
Biosensors and the evaluation of food contaminant biosensors in terms of their performance criteria
Burcu Aydın, E.; Aydın, M.; Kemal Sezgintürk, M. (Taylor and Francis Ltd., 2020)Biosensor technology has been extensively investigated for determination of several analytes in clinical diagnosis, food analysis and environmental monitoring. A biosensor includes three parts; a transducer, a bioreceptor ... -
Biosensors in Drug Discovery and Drug Analysis
Aydın, Elif Burcu; Aydın, Muhammet; Sezgintürk, Mustafa Kemal (Bentham Science Publ Ltd, 2019)Background: The determination of drugs in pharmaceutical formulations and human biologic fluids is important for pharmaceutical and medical sciences. Successful analysis requires low sensitivity, high selectivity and minimum ...